Meta-analysis | Heterogeneity | ||||||
---|---|---|---|---|---|---|---|
Outcomes | N. of studies | N. of participants | ES (95% CI) | P value effect | Q statistic | I-squared (%) | P value |
Survival | 3 | 869 | 2.082 (0.638–6.796) | 0.225 | 9.310 | 78.517 | 0.010 |
ROSC | 3 | 869 | 2.281 (1.304–3.989) | 0.004 | 5.454 | 63.328 | 0.065 |
MAP during CPR | 2 | 368 | 1.069 (0.851–1.288) |  < 0.001 | 0.080 | 0.000 | 0.777 |
MAP 15–20 min after CPR | 2 | 368 | 0.831 (0.553–1.110) |  < 0.001 | 0.503 | 33.446 | 0.220 |
Ventilator free days | 3 | 869 | 0.201 (− 0.677 to 1.079) | 0.838 | 44.108 | 95.466 |  < 0.001 |
Renal failure free days | 2 | 368 | 0.590 (0.312–0.869) |  < 0.001 | 0.043 | 0.0001 | 0.836 |
Insulin requirement | 3 | 869 | 1.711 (1.324–2.212) |  < 0.001 | 1.060 | 0.0001 | 0.589 |
Coagulation failure free days | 2 | 368 | 0.403 (0.128–0.679) | 0.004 | 0.271 | 0.0001 | 0.603 |